Clinical Trial Update: Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) [Phase 2]

View source ↗

Summary

This entry notes a Phase 2 clinical trial (ExBAT) evaluating extreme bipolar androgen therapy with darolutamide and testosterone cypionate in metastatic castrat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Darolutamide (darolutamide)
• Testosterone cypionate (testosterone cypionate)

Snippet

Sponsor: Latin American Cooperative Oncology Group | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING